Viridian Therapeutics Inc
Change company Symbol lookup
Select an option...
VRDN Viridian Therapeutics Inc
CRIS Curis Inc
PIXY ShiftPixy Inc
RVLP RVL Pharmaceuticals PLC
NAUT Nautilus Biotechnology Inc
BOF BranchOut Food Inc
SPRC Scisparc Ltd
NRSN Neurosense Therapeutics Ltd
ACNT Ascent Industries Co
FATH Fathom Digital Manufacturing Corp

Health Care : Biotechnology | Small Cap Blend
Company profile

Viridian Therapeutics, Inc. is a biotechnology company focused on discovering and developing medicines for serious and rare diseases. The Company is engaged in developing three product candidates, VRDN-001, VRDN-002, and VRDN-003, that is developed for intravenous (IV) or subcutaneous administration to treat patients who suffer from thyroid eye disease (TED). Its lead product candidate, VRDN-001, is a differentiated humanized monoclonal antibody targeting insulin-like growth factor-1 receptor (IGF-1R), a clinically and commercially validated target for the TED. It has initiated a Phase I/II clinical trial of VRDN-001. Its second product candidate, VRDN-002, is a distinct IGF-1R antibody that incorporates half-life extension technology, and is designed to support administration as a convenient, low volume, subcutaneous injection to treat patients who suffer from TED. VRDN-003 is an anti-IGF-1R monoclonal antibody with the same amino acid sequence as VRDN-001.


Last Trade
0.00 (0.00%)
B/A Size

Market Hours

Closing Price
Day's Change
0.18 (1.19%)
Bid close
Ask close
B/A Size
Day's High
Day's Low
(Above Average)

10-day average volume:

Upcoming Events

VRDN's fiscal year ends in December
There are no upcoming events for VRDN

Past Earnings

This page reports .
DateEvent descriptionEarnings per
share actual
estimate range
Previous year's
August 8, 2023Q2 2023 Earnings Release-$1.27-$1.69 to -$0.97-$1.06
May 9, 2023Q1 2023 Earnings Release-$1.61-$1.23 to -$0.82-$0.98
March 8, 2023Q4 2022 Earnings Release-$1.13-$0.94 to -$0.50-$1.32
November 14, 2022Q3 2022 Earnings Release-$0.86-$1.24 to -$0.48-$1.25

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

, , , Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.